AAC Holdings Inc (AAC) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 26 from a previous price target of $24 . Mizuho advised their investors in a research report released on Jul 18, 2016.
Many Wall Street Analysts have commented on AAC Holdings Inc. Mizuho Upgraded AAC Holdings Inc on May 25, 2016 to ” Buy”, Price Target of the shares are set at $24.
On the company’s financial health, AAC Holdings Inc reported $0.20 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on May 5, 2016. Analyst had a consensus of $0.17. The company had revenue of $65.30 million for the quarter, compared to analysts expectations of $59.26 million. The company’s revenue was up 52.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.15 EPS.
AAC Holdings Inc opened for trading at $23.04 and hit $23.0999 on the upside on Friday, eventually ending the session at $22.99, with a gain of 0.31% or 0.07 points. The heightened volatility saw the trading volume jump to 60,147 shares. Company has a market cap of $545 M.
In a different news, on Jul 15, 2016, Michael T. Cartwright (Chairman and CEO) sold 17,898 shares at $23.01 per share price. According to the SEC, on Jul 5, 2016, Kathryn Sevier Phillips (General Counsel and Secretary) sold 3,500 shares at $23.00 per share price. On Jul 5, 2016, Kirk R. Manz (Chief Financial Officer) sold 7,300 shares at $22.52 per share price, according to the Form-4 filing with the securities and exchange commission.
AAC Holdings Inc. is a provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company operates approximately seven residential substance abuse treatment facilities and one outpatient substance abuse treatment facility. Its substance abuse treatment facilities are located throughout the United States focused on delivering clinical care and treatment solutions across its approximately 560 beds which includes approximately 378 licensed detoxification beds. It has made investments in its treatment facilities. The Company provides care to adults and adolescents struggling with alcohol and/or drug abuse and dependence as well as co-occurring mental health issues. The Company offers various treatment services which include detoxification residential treatment partial hospitalization and intensive outpatient services.